SENS stock news

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced today that Eversense users who download the new Eversense® CGM mobile app can start dosing insulin based off of the readings from their Eversense System without the need to do a confirmatory blood glucose fingerstic Read more
Senseonics (NYSEAMERICAN:SENS) was downgraded by investment analysts at Canaccord Genuity from a “buy” rating to a “hold” rating in a research report issued on Wednesday, The Fly reports. They presently have a $1.00 price target on the stock, down from their previous price target of $2.00. Canaccord Genuity’s price target indicates a potential upside of […] Read more
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the quarter ended September 30, 2019. Recent Highlights & Accomplishments: Total net revenue of $4.3 million OUS net revenue of $3.8 million U.S. net revenue of $0.5 million after acc Read more
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today announced that it plans to release its third quarter 2019 financial results after market close on Tuesday, November 12, 2019. Management will hold a conference call to review the company’s third quarter 2019 performanc Read more
Senseonics (SENS) delivered earnings and revenue surprises of -6.25% and 1.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
In 2015 Tim Goodnow was appointed CEO of Senseonics Holdings, Inc. (NYSEMKT:SENS). This report will, first, examine… Read more
SENS earnings call for the period ending March 31, 2019. Read more
The continuous glucose system (CGM) maker posted solid revenue growth but missed Wall Street's revenue and earnings estimates. Read more
Q1 2019 Senseonics Holdings Inc Earnings Call Read more
Senseonics Holdings, Inc. (NYSEMKT:SENS) Q1 2019 Earnings Conference Call May 9, 2019, 04:30 PM ET Company Participants Philip Taylor - Associate, Gilmartin Gro Read more

Senseonics Q1 2019 Earnings Preview

09:35pm, Wednesday, 08'th May 2019
Read more
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At

ROCKIT